Account
Inquiry
Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for metabolic research applications. This white powder formulation offers researchers high purity material for laboratory studies.
The compound demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists. Its unique dual agonist behavior produces significant reductions in hyperglycemia through simultaneous action on both GIP and GLP-1 receptors.
Our tirzepatide raw material is produced under strict quality control standards, with trifluoroacetic acid (TFA) completely removed for research safety. The product is vacuum-sealed in vials to maintain stability and purity.
Key research applications include metabolic syndrome studies, diabetes research, and obesity-related investigations. The compound has shown potential in converting white adipose tissue to brown fat and improving leptin sensitivity in preclinical models.
For research purposes only. Not for human consumption. Proper storage at -20°C is recommended for long-term stability. Researchers should follow all laboratory safety protocols when handling this material.
